Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04232670 · ClinicalTrials.gov registry record · NA
Pancreatic Endotherapy for Refractory Chronic Pancreatitis
A NA study, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT04232670 is a NA study that has completed, run by Oregon Health and Science University. The registered enrollment target is 14 participants.
The verdict
NCT04232670, a NA study, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate whether endoscopic ultrasound (EUS) only versus EUS + endoscopic retrograde cholangiopancreatography (ERCP) with pancreatic endotherapy reduces pain in the treatment of chronic pancreatitis with pancreatic duct obstruction.
Interventions
- PROCEDURE EUS + SHAM
- PROCEDURE EUS + Pancreatic Endotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2020-10-09 |
| Est. Completion | 2024-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04232670
The ClinicalTrials.gov registry entry for NCT04232670 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which EUS + SHAM is the first listed.
NCT04232670 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04232670 about?
NCT04232670 is a clinical study titled "Pancreatic Endotherapy for Refractory Chronic Pancreatitis". The purpose of this study is to evaluate whether endoscopic ultrasound (EUS) only versus EUS + endoscopic retrograde cholangiopancreatography (ERCP) with pancreatic endotherapy reduces pain in the treatment of chronic pancreatitis with pancreatic duct obstruction.
What is the current status of trial NCT04232670?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2020-10-09. Estimated completion is 2024-06-30.
What interventions are being tested in trial NCT04232670?
The interventions under investigation include: EUS + SHAM (PROCEDURE), EUS + Pancreatic Endotherapy (PROCEDURE).
Who is sponsoring clinical trial NCT04232670?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.